Aksit, ErcanKucuk, UgurTaylan, GokayCinier, GokselKarabay, Can YucelAkgun, Taylan2025-01-272025-01-2720220167-52731874-1754https://doi.org/10.1016/j.ijcard.2022.01.025https://hdl.handle.net/20.500.12428/28277[Anstract Not Available]eninfo:eu-repo/semantics/closedAccessAnti-fibrotic drugsArrhythmogenic cardiomyopathyCardiac fibrosisRemodelingThe importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasiaLetter353535310.1016/j.ijcard.2022.01.025Q2WOS:0007843305000122-s2.0-8512630146635051491Q1